Evidence map›Paper›PMID 36555244›Full record

ArticleInternational journal of molecular sciences2022

Melanins from the Lichens

Anna Rassabina, Venera Khabibrakhmanova, Vasily Babaev, Amina Daminova, Farida Minibayeva

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Secondary metabolites fromRSC advances · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Topography of UV-Melanized Thalli ofPlants (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anna RassabinaKazan Institute of Biochemistry and Biophysics, FRC Kazan Scientific Center of RAS, 2/31, Lobachevsky Str., Kazan 420111, Russia.ORCID 0000-0003-0397-6474
Venera KhabibrakhmanovaKazan Institute of Biochemistry and Biophysics, FRC Kazan Scientific Center of RAS, 2/31, Lobachevsky Str., Kazan 420111, Russia.
Vasily BabaevArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of RAS, 8, Academician Arbuzov Str., Kazan 420088, Russia.
Amina DaminovaKazan Institute of Biochemistry and Biophysics, FRC Kazan Scientific Center of RAS, 2/31, Lobachevsky Str., Kazan 420111, Russia.
Farida MinibayevaKazan Institute of Biochemistry and Biophysics, FRC Kazan Scientific Center of RAS, 2/31, Lobachevsky Str., Kazan 420111, Russia.ORCID 0000-0003-0827-181X
Kazan Institute of Biochemistry and Biophysics · RUA.E. Arbuzov Institute of Organic and Physical Chemistry · RU

Funding

Russian Foundation for Basic Research 20-34-90044Russian Science Foundation 18-14-00198
6 · The paper itself

Abstract

Synthetic dyes are widely used in the industry; they are chemically stable, difficult to neutralize, and therefore they are a threat to the environment when released into wastewaters. The dyes have a significant impact on plant performance by impairing photosynthesis, inhibiting growth, and entering the food chain and may finally result in the toxicity, mutagenicity and carcinogenicity of food products. Implementation of the dark piment melanin for the adsorption of the synthetic dyes is a new ecologically friendly approach for bioremediation. The aim of the present work was to study the physico-chemical characteristics of melanins from the lichens

Indexed as

LichensMelaninsAscomycotaColoring AgentsColoring AgentsMelaninsadsorbentsFT-IRlichensmelaninssynthetic dyes

Identifiers

PMID36555244
PMCPMC9779828
OpenAlexW4311968188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.